Cargando…
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma
BACKGROUND: Lung cancer is the number one cancer killer of both men and women in the United States. Three quarters of lung cancer patients are diagnosed with regionally or distantly disseminated disease; their 5-year survival is only 15%. DNA hypermethylation at promoter CpG islands shows great prom...
Autores principales: | Tsou, Jeffrey A, Galler, Janice S, Siegmund, Kimberly D, Laird, Peter W, Turla, Sally, Cozen, Wendy, Hagen, Jeffrey A, Koss, Michael N, Laird-Offringa, Ite A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206053/ https://www.ncbi.nlm.nih.gov/pubmed/17967182 http://dx.doi.org/10.1186/1476-4598-6-70 |
Ejemplares similares
-
Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer
por: Anglim, Paul P, et al.
Publicado: (2008) -
The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma
por: Kerr, Keith M., et al.
Publicado: (2007) -
DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma
por: Selamat, Suhaida A., et al.
Publicado: (2011) -
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
por: Selamat, Suhaida A., et al.
Publicado: (2012) -
Transcriptomic profiling of primary alveolar epithelial cell differentiation in human and rat
por: Marconett, Crystal N., et al.
Publicado: (2014)